GFAP and Hypercholesterolemia: The only exception was GFAP, which was significantly increased in CU participants with hypercholesterolemia (p = 0.01) and a marginally significant decrease in MCI participants with diabetes (p = 0.5; Figure S1 in Supplementary Materials).